Search by Drug Name or NDC
NDC 00363-7214-25 EXTRA STRENGTH HEADACHE RELIEF 250; 250; 65 mg/1; mg/1; mg/1 Details
EXTRA STRENGTH HEADACHE RELIEF 250; 250; 65 mg/1; mg/1; mg/1
EXTRA STRENGTH HEADACHE RELIEF is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by WALGREENS. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 00363-7214 |
|---|---|
| Product ID | 0363-7214_0c060dc6-7ccb-92be-e063-6294a90a2b27 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | EXTRA STRENGTH HEADACHE RELIEF |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ACETAMINOPHEN, ASPIRIN, CAFFEINE |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | WALGREENS |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M013 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00363-7214-25 (00363721425)
| NDC Package Code | 0363-7214-25 |
|---|---|
| Billing NDC | 00363721425 |
| Package | 250 TABLET in 1 BOTTLE (0363-7214-25) |
| Marketing Start Date | 2020-11-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |